Bodick Neil 4
4 · Flexion Therapeutics Inc · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Award
Common Stock
2019-03-01+36,000→ 100,782 total - Award
Stock option (right to buy)
2019-03-01+18,000→ 18,000 totalExercise: $14.75Exp: 2029-02-28→ Common Stock (18,000 underlying)
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The shares are held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest one year after January 1, 2019 (the "Vesting Commencement Date") and thereafter one-forty-eighth (1/48th) of the total shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four (4) years after the Vesting Commencement Date.